We use cookies to improve your experience on our site. By using our site you consent to the use of cookies. Learn More
Applications for the Trinity Challenge on Antimicrobial Resistance are now closed Read submitted solutions here
24 February 2021
Updated 3rd June 2021
London, UK, 24 February 2021: The Trinity Challenge, launched by Dame Sally Davies in September 2020, is excited to announce that we are now open for submissions to the inaugural round of our public Challenge. Winners could be awarded part of a prize pot of up to £6M towards their solutions to some of the world’s most pressing pandemic problems.
Since our launch in September, we have received a high level of interest, with individuals and organisations from across sectors and geographies, eager to connect with our Members, form teams, and work on solutions for our public Challenge. We are now accepting final submissions, which will be reviewed by our expert panel of reviewers and judges, who represent a wide range of disciplines and backgrounds.
The Trinity Challenge seeks solutions that use data and analytics to better identify, respond to, or recover from health emergencies, covering economics, behavioural sciences, epidemiology and many other disciplines.
We are excited to be partnering with MIT Solve to deliver our inaugural Challenge. MIT Solve has a strong track record of hosting open innovation challenges for social impact on their award-winning platform.
The portal for submissions has been officially opened at our Town Hall event, on February 24th. Information on how to submit a solution, or more generally on our Challenge processes, is available at the submission platform (https://solve.mit.edu/challenges/the-trinity-challenge). We also welcome questions at info[at]thetrinitychallenge.com
We are looking forward to receiving your solutions!
-------------
Notes to editors
Our CEO Hala Audi and other leaders from the Founding Members are available for interviews on request, please call +44 07525 897441, Hebe Trotter, Brunswick Group
Perceptions of the importance & effectiveness of the vaccines declined between June 2020 & January 2022.
"In my experience, no community is too hard to reach, no country is too poor to innovate, and curiosity outshines fear across the globe," says Dr Mark Smolinski, writing in the Stanford Social Innovation Review.
Unused, discarded data points from billions of routine blood tests are a potential treasure trove for disease detection.